Long Term Debt - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Long-Term Debt Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Long-Term Debt
zł26.1m
CAGR 3-Years
90%
CAGR 5-Years
2%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Long-Term Debt
zł0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Long-Term Debt
zł0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Long-Term Debt
zł176.1m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Long-Term Debt?
Long-Term Debt
26.1m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Long-Term Debt amounts to 26.1m PLN.

What is Ryvu Therapeutics SA's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
2%

Over the last year, the Long-Term Debt growth was 3 682%. The average annual Long-Term Debt growth rates for Ryvu Therapeutics SA have been 90% over the past three years , 2% over the past five years .

Back to Top